1. Home
  2. XGN vs FBIO Comparison

XGN vs FBIO Comparison

Compare XGN & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$3.65

Market Cap

71.2M

Sector

Health Care

ML Signal

HOLD

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$2.25

Market Cap

78.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XGN
FBIO
Founded
2002
2006
Country
United States
United States
Employees
N/A
78
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.2M
78.3M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
XGN
FBIO
Price
$3.65
$2.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$8.86
$17.00
AVG Volume (30 Days)
365.2K
259.5K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.12
$55.22
Revenue Next Year
$13.00
$40.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.59
$1.66
52 Week High
$12.23
$4.53

Technical Indicators

Market Signals
Indicator
XGN
FBIO
Relative Strength Index (RSI) 61.64 38.11
Support Level $3.15 $2.20
Resistance Level $3.89 $2.49
Average True Range (ATR) 0.27 0.10
MACD 0.10 0.02
Stochastic Oscillator 62.91 5.41

Price Performance

Historical Comparison
XGN
FBIO

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

Share on Social Networks: